Expression and activation of the BMP-signaling components in human fracture nonunions

Journal of Bone and Joint Surgery

Volumn 84, Issue 11, 2002, Pages 1909-1918

  Kloen, Peter ^a   Doty, Steven B ^a   Gordon, Eric ^a   Rubel, Iván F ^a   Goumans, Marie José ^a   Helfet, David L ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; BONE MORPHOGENETIC PROTEIN RECEPTOR IA; BONE MORPHOGENETIC PROTEIN RECEPTOR IB; OSTEOGENIC PROTEIN 1; SMAD PROTEIN; SMAD1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; FEMALE; FRACTURE NONUNION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

EID: 0036844344     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200211000-00001     Document Type: Article

References (60)

1. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem. 1994;56:283-94.
2. Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop. 1998;355 Suppl:S7-21.
3. Einhorn TA, Lee CA. Bone regeneration: New findings and potential clinical applications. J Am Acad Orthop Surg. 2001;9:157-65.
4. Yoo JU, Johnstone B. The role of osteochondral progenitor cells in fracture repair. Clin Orthop. 1998;355 Suppl:S73-81.
5. Groeneveld EH, Burger EH. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol. 2000;142:9-21.
6. Kingsley DM. Bone morphogenetic proteins in the formation and repair of cartilage, bone and joints. In: Buckwalter JA, Ehrlich MG, Sandell LJ, Trippel SB, editors. Skeletal Growth and Development: Clinical Issues and Basic Science Advances. Rosemont, IL: American Academy of Orthopaedic Surgeons; 1998. p 87-98.
7. Miyazono K. Signal transduction by bone morphogenetic protein receptors: Functional roles of Smad proteins. Bone. 1999;25:91-3.
8. Rauch F, Lauzier D, Croteau S, Travers R, Glorieux FH, Hamdy R. Temporal and spatial expression of bone morphogenetic protein-2, -4, and -7 during distraction osteogenesis in rabbits. Bone. 2000;26:611-7.
9. Reddi AH. Initiation of fracture repair by bone morphogenetic proteins. Clin Orthop. 1998;355 Suppl:S66-72.
10. Reddi AH. Bone morphogenetic proteins: From basic science to clinical applications. J Bone Joint Surg Am. 2001;83 Suppl 1(Pt 1):S1-6.
11. Sakou T. Bone morphogenetic proteins: From basic studies to clinical approaches. Bone. 1998;22:591-603.
12. Schmitt JM, Hwang K, Winn SR, Hollinger JO. Bone morphogenetic proteins: An update on basic biology and clinical relevance. J Orthop Res. 1999;17:269-78.
13. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop. 1998;346:26-37.
14. Yamashita H, Ten Dijke P, Heldin CH, Miyazono K. Bone morphogenetic protein receptors. Bone. 1996;19:569-74.
15. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997;390:465-71.
16. Bouxsein ML, Turek TJ, Blake CA, D'Augusta D, Li X, Stevens M, Seeherman HJ, Wozney JM. Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. J Bone Joint Surg Am. 2001;83:1219-30.
17. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC, Whitecloud TS. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am. 1994;76:827-38.
18. Cook SD, Salkeld SL, Brinker MR, Wolfe MW, Rueger DC. Use of an osteoinductive biomaterial (rhOP-1) in healing large segmental bone defects. J Orthop Trauma. 1998;12:407-12.
19. Heckman JD, Boyan BD, Aufdemorte TB, Abbott JT. The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg Am. 1991;73:750-64.
20. Johnson EE, Urist MR, Finerman GA. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin Orthop. 1988;230:257-65.
21. Johnson EE, Urist MR, Finerman GA. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. Clin Orthop. 1988;236:249-57.
22. Johnson EE, Urist MR, Finerman GA. Distal metaphyseal tibial nonunion. Deformity and bone loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP). Clin Orthop. 1990;236:234-40.
23. Johnson EE, Urist MR, Finerman GA. Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. Clin Orthop. 1992;277:229-37.
24. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83 Suppl 1(Pt 2):S151-8.
25. Geesink RG, Hoefnagels NH, Bulstra SK. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br. 1999;81:710-8.
26. Hietaniemi K, Lehto MU, Paavolainen P. Major fibrillar collagens and fibronectin in an experimental nonunion: An immunohistochemical study. Acta Orthop Scand. 1998;69:545-9.
27. Hietaniemi K, Paavolainen P, Penttinen R. Connective tissue parameters in experimental nonunion. J Orthop Trauma. 1996;10:114-8.
28. Schmitz JP, Schwartz Z, Hollinger JO, Boyan BD. Characterization of rat calvarial nonunion defects. Acta Anat. 1990;138:185-92.
29. Guerkov HH, Lohmann CH, Liu Y, Dean DD, Simon BJ, Heckman JD, Schwartz Z, Boyan BD. Pulsed electromagnetic fields increase growth factor release by nonunion cells. Clin Orthop. 2001;384:265-79.
30. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A. 1995;92:7632-6.
31. ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K, Heldin CH. Characterization of type I receptors for transforming growth factor-beta and activin. Science. 1994;264:101-4.
32. Hayashi K, Ishldou Y, Yonemorl K, Nagamine T, Origuchl N, Maeda S, Imamura T, Kato M, Yoshida H, Sampath K, ten Dijke P, Sakou T. Expression and localization of bone morphogenetic proteins (BMPs) and BMP receptors in ossification of the ligamentum flavum. Bone. 1997;21:23-30.
33. Ishidou Y, Kitajima I, Obama H, Maruyama I, Murata F, Imamura T, Yamada N, ten Dijke P, Miyazono K, Sakou T. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res. 1995;10:1651-9.
34. Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, Kato M, Sampath TK, ten Dljke P, Sakou T. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone. 1998;22:605-12.
35. Sakou T, Onishl T, Yamamoto T, Nagamlne T, Sampath T, Ten Dijke P. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification. J Bone Miner Res. 1999;14:1145-52.
36. Yonemori K, Imamura T, Ishidou Y, Okano T, Matsunaga S, Yoshida H, Kato M, Sampath TK, Miyazono K, ten Dijke P, Sakou T. Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament. Am J Pathol. 1997;150:1335-47.
37. Persson U, Izumi H, Souchelnytskyi S, Itoh S, Grimsby S, Engstrom U, Heldin CH, Funa K, ten Dijke P. The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation. FEBS Lett. 1998;434:83-7.
38. Schenk RK. Biology of fracture repair. In: Browner BD, Jupiter JB, Levine AM, Trafton PG, editors. Skeletal Trauma. Philadelphia: WB Saunders; 1992. p 31-75.
39. Andrew JG, Hoyland J, Andrew SM, Freemont AJ, Marsh D. Demonstration of TGF-beta 1 mRNA by in situ hybridization in normal human fracture healing. Calcif Tissue Int. 1993;52:74-8.
40. Bostrom M, Lane JM, Tomin E, Browne M, Berberian W, Turek T, Smith J, Wozney J, Schildhauer T. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop. 1996;327:272-82.
41. McKibbin B. The biology of fracture healing in long bones. J Bone Joint Surg Br. 1978;60:150-62.
42. Nakase T, Nomura S, Yoshikawa H, Hashimoto J, Hirota S, Kitamura Y, Oikawa S, Ono K, Takaoka K. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res. 1994;9:651-9.
43. Bostrom MP, Lane JM, Berberian WS, Missri AA, Tomin E, Weiland A, Doty SB, Glaser D, Rosen VM. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res. 1995;13:357-67.
44. Yoshimura Y, Nomura S, Kawasaki S, Tsutsumimoto T, Shimizu T, Takaoka K. Colocalization of noggin and bone morphogenetic protein-4 during fracture healing. J Bone Miner Res. 2001;16:876-84.
45. Sato M, Ochi T, Nakase T, Hirota S, Kitamura Y, Nomura S, Yasui N. Mechanical tension-stress induces expression of bone morphogenetic protein (BMP)-2 and BMP-4, but not BMP-6, BMP-7, and GDF-5 mRNA, during distraction osteogenesis. J Bone Miner Res. 1999;14:1084-95.
46. Pauwels F. Biomechanics of the Normal and Diseased Hip: Theoretical Foundation, Technique, and Results of Treatment. New York: Springer; 1976.
47. Weber BG, Cech O. Pseudarthrosis: Pathophysiology, Biomechanics, Therapy, Results. Kostam P, transl. New York: Grune and Stratton; 1976.
48. Müller ME. Treatment of nonunions by compression. Clin Orthop. 1965;43:83-92.
49. Ring D, Barrick WT, Jupiter JB. Recalcitrant nonunion. Clin Orthop. 1997;340:181-9.
50. Rosen H. Compression treatment of long bone pseudarthroses. Clin Orthop. 1979;138:154-66.
51. Boyan BD, Caplan AI, Heckman JD, Lennon DP, Ehler W, Schwartz Z. Osteochondral progenitor cells in acute and chronic canine nonunions. J Orthop Res. 1999;17:246-55.
52. Meyer RA, Meyer MH, Pheiffer LS, Banks DM. Delayed union of femoral fractures in older rats: Decreased gene expression. BMC Musculosketet Disord. 2001;2:2.
53. Boyan BD, Schwartz Z, Swain LD, Khare AG, Heckman JD, Ramirez V, Peters P, Carnes DL Jr. Initial effects of partially purified bone morphogenetic protein on the expression of glycosaminoglycan, collagen and alkaline phosphatase in nonunion cell cultures. Clin Orthop. 1992;278:286-304.
54. Brownlow HC, Simpson AH. Metabolic activity of a new atrophic nonunion model in rabbits. J Orthop Res. 2000;18:438-42.
55. Aspenberg P, Basic N, Tagil M, Vukicevic S. Reduced expression of BMP-3 due to mechanical loading: A link between mechanical stimuli and tissue differentiation. Acta Orthop Scand. 2000;71:558-62.
56. Le AX, Miclau T, Hu D, Helms JA. Molecular aspects of healing in stabilized and non-stabilized fractures. J Orthop Res. 2001;19:78-84.
57. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol. 2000;20:8783-92.
58. Lee JY, Musgrave D, Pelinkovic D, Fukushima K, Cummins J, Usas A, Robbins P, Fu FH, Huard J. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am. 2001;83:1032-7.
59. Service RF. Tissue engineers build new bone [news]. Science. 2000;289:1498-500.
60. Musgrave DS, Pruchnic R, Bosch P, Ziran BH, Whalen J, Huard J. Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. J Bone Joint Surg Br. 2002;84:120-7.